8-K
filed March 10, 2025, 7:59 PM ET
ticker ANGI
CIK 0001705110
other material
confidence high
sentiment neutral
materiality 0.70
Angi announces 1-for-10 reverse stock split effective March 24, spin-off from IAC on March 31
Angi Inc.
- Reverse stock split at 1-for-10 ratio for Class A and Class B common stock effective March 24, 2025.
- IAC to distribute all its Angi shares as a special dividend on March 31, 2025 to IAC stockholders of record March 25.
- Approximately 0.5178 Angi shares per IAC share expected based on current counts; cash for fractional shares.
- After spin-off, IAC will own no Angi stock; Angi trades under 'ANGI' on Nasdaq with when-issued trading prior to distribution.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001104659-25-021974
- form_type
- 8-K
- ticker
- ANGI
- cik
- 0001705110
- company_name
- Angi Inc.
- filed_at
- 2025-03-10T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:04.512173+00:00
- generated_at
- 2026-05-25T01:48:08.990090+00:00
- sec_items
- ["8.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001104659-25-021974
- json_url
- https://secwatch.observer/filing/0001104659-25-021974.json
- markdown_url
- https://secwatch.observer/filing/0001104659-25-021974.md
- text_url
- https://secwatch.observer/filing/0001104659-25-021974.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1705110/000110465925021974/0001104659-25-021974-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1705110/000110465925021974/tm258609d1_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
XMTR
Xometry announces public offering of 2.65M shares at $85.00; expected net proceeds $215.2M
Xometry, Inc.
June 2, 2026, 5:26 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
ARVN
Arvinas to out-license ARV-806 after completing Phase 1 dose escalation
ARVINAS, INC.
June 2, 2026, 4:39 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
TTI
TETRA announces $100M common stock offering, Arkansas Bromine Project approved with $220M remaining capex
TETRA TECHNOLOGIES INC
June 2, 2026, 4:26 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
CEG
Constellation Energy secondary offering of 11M shares with concurrent $558M share repurchase
Constellation Energy Corp
June 2, 2026, 4:15 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
CNL Strategic Capital, LLC
Shareholders reject enhanced liquidity plan (25% repurchase); loan amended for equity buybacks
CNL Strategic Capital, LLC
June 2, 2026, 4:04 PM ET
other_material
Items 1.01, 2.03, 5.07, 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
INMB
INmune Bio reports statistically significant white matter MRI biomarker in Phase 2 Alzheimer's trial
Inmune Bio, Inc.
June 2, 2026, 4:00 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
MBOT
Microbot Medical secures first North Carolina customer for LIBERTY robotic system
Microbot Medical Inc.
June 2, 2026, 8:30 AM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
URGN
UroGen settles patent litigation with Teva over Jelmyto; generic entry Sept 15, 2030
UroGen Pharma Ltd.
June 2, 2026, 8:04 AM ET
other_material
Items 8.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.